Manguben Ishwarlal Patel 's Insider Trades & SAST Disclosures

Visit FAQs

Manguben Ishwarlal Patel 's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 51,050 Equity Shares done . Disclosure was reported to the exchange on March 16, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Manguben Ishwarlal Patel 's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 51,050 shares done . Disclosure was reported to the exchange on March 16, 2023.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Lincoln Pharma
Manguben Ishwarlal Patel & PACs Promoter Acquisition 17 Mar 2023 51,050 145,140 (0.72%) 0.25% - 15 Mar 2023
15 Mar 2023		 SAST (29(2)) - Transmission
Lincoln Pharma
MANGUBEN ISHWARLAL PATEL Promoter Group Acquisition 16 Mar 2023 51,050 145,140 (0.72%) 0.25% 0 0 15 Mar 2023
15 Mar 2023		 Insider Trading Equity Shares Inheritance
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST